Premium
Theranos Experience Exposes Weaknesses in FDA Regulatory Discretion
Author(s) -
Jotwani Rohan,
Boumil Marcia,
Salem Deeb,
Wetterhahn Madeline,
Beninger Paul
Publication year - 2017
Publication title -
clinical pharmacology in drug development
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.711
H-Index - 22
eISSN - 2160-7648
pISSN - 2160-763X
DOI - 10.1002/cpdd.374
Subject(s) - medicine , discretion , drug approval , strengths and weaknesses , internet privacy , pharmacology , law , social psychology , drug , political science , psychology , computer science